Costs as between Dr Darshn and Avant
11 Dr Darshn seeks an order that Avant pay his costs of this proceeding up to and including 25 June 2021 on an indemnity basis, and that Avant pay his costs on and from 26 June 2021 on a party-party basis.
12 Further, Dr Darshn seeks an order that $340,000 (or such other amount as the Court considers appropriate) be paid within seven days, by way of partial satisfaction of his entitlement to costs. As for the balance of the costs, Dr Darshn seeks an order that these be fixed by way of a lump sum costs process in accordance with the Court's Costs Practice Note (GPN-COSTS).
13 In support of the application for indemnity costs, Dr Darshn relies on Avant's conduct in denying his claim for indemnity and Avant's conduct of the proceeding (in particular, its conduct relating to the production of documents). In the alternative, Dr Darshn relies on the service of a Calderbank letter on 13 April 2021 (a copy of which appears at pp 480-485 of Exhibit RI-1 to Mr Ishak's 22 July 2021 affidavit).
14 Dr Darshn seeks an order that Avant pay his costs of the proceeding as a whole; that is, an order that Avant pay the costs of his claims against MIGA as well as Avant.
15 Avant accepts that, given the outcome of the proceeding, there should be an order that it pay Dr Darshn's costs of his claims against Avant. Avant contends that such costs should be determined on a party-party basis. Avant contends that any costs order in Dr Darshn's favour should not cover his costs of pursuing claims against MIGA, which it says were already dealt with in an order that those claims be dismissed with "no order as to costs" (see [5] of the reasons for judgment dated 25 June 2021). Further, Avant submits that there should not be any advance of money towards Dr Darshn's costs, given his impecuniosity and the prospect of an appeal. In relation to a lump sum costs order, Avant submits that the material to support the lump-sum amount should already have been filed and served by Dr Darshn, but he has not done so.
16 In my view, the matters relied on by Dr Darshn in support of an order for indemnity costs are not sufficient to justify the making of such an order. The principles applicable to the making of such an order are set out in Colgate-Palmolive Co v Cussons Pty Ltd (1993) 46 FCR 225 at 232-234 per Sheppard J; see also Melbourne City Investments Pty Ltd v Treasury Wine Estates Ltd (No 2) [2017] FCAFC 116 (Melbourne City Investments) at [5] per Jagot, Yates and Murphy JJ.
17 In the present case, while I have concluded (at [229] of the reasons for judgment of 25 June 2021) that Avant breached its duty of utmost good faith in rejecting Dr Darshn's claim for indemnity, I am not satisfied that this should result in an order for indemnity costs in relation to the proceeding. In particular, Avant's defence of the proceeding does not fall into any of the categories described by the Full Court in Melbourne City Investments.
18 As for Avant's conduct of the proceeding, while it is true that Avant resisted the production of certain documents, including on the ground of legal professional privilege, and was ordered to produce the documents, I do not infer from the circumstances that there was any improper conduct on the part of Avant or conduct of such a nature that would justify making an order for indemnity costs. An order in Dr Darshn's favour on a party-party basis will reflect the fact that Dr Darshn was successful in respect of the document-production issues.
19 In relation to the Calderbank letter, in my view, the letter does not contain a sufficient element of compromise to make it unreasonable for Avant to have rejected it: see Veda Advantage Limited v Malouf Group Enterprises Pty Limited (No 2) [2016] FCA 470 at [31] per Katzmann J. The letter from Dr Darshn's lawyers to Avant's lawyers contained the following offer:
(a) Your client agrees that Dr Darshn is entitled to be indemnified by them in respect of the TCI class action;
(b) On that basis, your client further agrees to reimburse Dr Darshn for his costs and expenses paid to date arising out of the TCI class action (and to indemnify him for further costs and expenses incurred but not paid to date, and for future costs and expenses);
(c) Our client agrees to the Federal Court proceedings being discontinued by consent pursuant to r 26.12(2)(b) of the Federal Court Rules 2011 (Cth);
(d) Our client agrees to an order that your client pay 70% of: (a) his party/party costs in the Federal Court proceedings; and (b) any liability for costs he incurs to the second respondent.
20 Apart from a modest reduction in costs, the offer did not contain any element of compromise. Accordingly, I do not consider this to provide a basis to order costs on an indemnity basis from the date of that letter.
21 For these reasons, I decline to make an order for the payment of costs on an indemnity basis.
22 I turn now to consider whether the costs order in Dr Darshn's favour should relate to his costs of the proceeding as a whole (i.e. his claims against Avant and MIGA) or only of his claims against Avant. While it is true that an order was made that Dr Darshn's claims against MIGA be dismissed with "no order as to costs", I consider that order to relate to issues of costs as between Dr Darshn and MIGA. I do not consider it to preclude an application by Dr Darshn against Avant in respect of the costs of pursuing his claims against MIGA.
23 There is some overlap between this issue and the question whether a Sanderson order should be made in favour of MIGA, discussed later in these reasons. I discuss the principles applicable to the making of a Bullock or Sanderson order later in these reasons. In my view, the same principles are relevant in considering whether Avant should be ordered to pay Dr Darshn's costs of pursuing his claims against MIGA. I consider it appropriate to order that Avant pay those costs. First, Dr Darshn acted reasonably in suing MIGA (and also acted reasonably in resolving his claims against MIGA when he did). Secondly, there was a substantial connection between the claims against Avant and the claims against MIGA. Thirdly, there was conduct by Avant that makes it fair to impose liability on Avant for these costs. I refer, in particular, to the correspondence at pages 5 and 7 of Exhibit RI-1 to Mr Ishak's 22 July 2021 affidavit (set out later in these reasons). Fourthly, balancing the competing considerations as set out in the parties' submissions, I consider it appropriate for Avant to bear these costs.
24 Accordingly, there should be an order that Avant pay Dr Darshn's costs of and incidental to the proceeding on a party-party basis.
25 As for the application for an advance payment towards costs, I consider it appropriate for there to be some advance payment (given Dr Darshn's entitlement to costs and the quantum of costs he has already paid: see Mr Ishak's affidavit of 22 July 2021 at paragraph 68), but I consider that the amount should be less than that sought by Dr Darshn. I consider an appropriate advance to be $182,000 reflecting the costs he has paid to date in respect of this proceeding. Having regard to the total costs incurred in respect of this proceeding (approximately $722,000 - see paragraph 66 of Mr Ishak's 22 July 2021 affidavit) it is reasonable to assume that the party-party costs will be at least $182,000. I will make this payable within 14 days.
26 As for a lump sum order, I consider it appropriate to make orders for the fixing of a lump sum in respect of Dr Darshn's costs, with the lump sum to be determined by a Registrar.